See every side of every news story
Published loading...Updated

#ORIC Pharmaceuticals Continues Strategic Inducement Grants to Bolster Oncology Expertise,

Summary by csimarket.com
ORIC Pharmaceuticals Announces Latest Inducement Grants Amidst Growth Momentum South San Francisco, Calif. and San Diego Feb. 7, 2025 - ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical-stage oncology firm at the forefront of developing treatments targeting therapeutic resistance, has unveiled its latest inducement grants under Nasdaq Listing Rule 5635(c)(4). In its most recent press release, delivered on February 7, 2025, the company announ…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

csimarket.com broke the news in on Tuesday, February 11, 2025.
Sources are mostly out of (0)